Do gamma-glutamyltransferase levels identify HCV patients who require lifelong post-SVR follow-up?

Liver Int. 2020 Mar;40(3):509-510. doi: 10.1111/liv.14394.

Authors

Francesca Colapietro^{1

2}, Alessio Aghemo^{1

2}

Affiliations

¹ Division of Internal Medicine and Hepatology, Department of Gastroenterology, Humanitas Clinical and Research Center IRCCS, Rozzano (MI), Italy.
² Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (MI), Italy.

PMID: 32124542
DOI: 10.1111/liv.14394

No abstract available

Publication types

Editorial
Comment

MeSH terms

Follow-Up Studies
Hepatitis C, Chronic*
Humans
Ribavirin
Risk Factors
gamma-Glutamyltransferase

Substances

Ribavirin
gamma-Glutamyltransferase